Can you tell us about the new guidelines and the new recommendations, including the new routine and

I think one of the most significant developments in the new NICE guideline is the recommendation for routine annual reviews for everyone diagnosed with PMOS.

This represents a shift away from seeing PMOS as something that only requires attention when symptoms become problematic.

The annual review is intended to provide a structured opportunity to assess how someone is doing across multiple aspects of their health.

That includes reviewing menstrual symptoms, concerns about excess hair growth or acne, fertility and pregnancy plans, medication use, weight management, mental well-being and symptoms that could suggest sleep apnoea.

Importantly, it also encourages clinicians to assess longer term health risks.

because people with PMOS have a higher risk of developing type 2 diabetes and cardiovascular disease regular monitoring provides an opportunity to identify problems early and offer preventive support another key theme running through the guideline is the emphasis on coordinated person-centered care PMOS can affect many aspects of life so management may involve primary care endocrinology fertility services mental health support and lifestyle interventions.

How can the new guideline help with this?